Summary & Overview
CPT 78012: Thyroid Radioiodine Uptake Study
Headline: CPT code 78012: Thyroid Radioiodine Uptake Study Used to Diagnose Thyroid Function
Lead: CPT code 78012 represents a diagnostic nuclear medicine procedure measuring oral radioiodine uptake by the thyroid 4–24 hours after ingestion to assess thyroid function and help determine causes of thyrotoxicosis.
CPT code 78012 captures a clinically important, noninvasive imaging study that directly measures thyroid iodine uptake to distinguish hyperthyroidism, hypothyroidism, and euthyroid states. Nationally, this procedure informs diagnosis and treatment planning for patients with suspected thyrotoxicosis, including autoimmune hyperthyroidism such as Graves' disease. It is performed primarily in outpatient imaging or nuclear medicine departments and is part of the broader endocrine diagnostic workup.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise explanation of the clinical purpose of the test, typical service setting, and the relevance of the study for managing thyroid disease. The publication also summarizes payer coverage context and common billing considerations, highlights benchmarks and utilization patterns where available, and outlines the immediate clinical and coding context that clinicians and billing teams need to consider when documenting and submitting claims for this service.
Billing Code Overview
CPT code 78012 describes a diagnostic nuclear medicine study in which the provider measures the amount of orally administered radioiodine that reaches the thyroid gland within a 4- to 24-hour period after ingestion. The test evaluates thyroid uptake to determine whether the gland is overactive (hyperthyroid), underactive (hypothyroid), or functioning normally, and is commonly used to investigate causes of thyrotoxicosis, such as Graves' disease or other hyperthyroid conditions.
Service Type: Thyroid radioiodine uptake study (diagnostic nuclear medicine)
Typical Site of Service: Outpatient imaging or nuclear medicine department, often in hospital outpatient settings or freestanding imaging centers. Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 45-year-old female with symptoms of palpitations, weight loss, heat intolerance, and tremor is referred to nuclear medicine by her endocrinologist to evaluate suspected hyperthyroidism. The provider administers an oral diagnostic dose of radioiodine (I-123 or I-131 depending on institutional protocol) and measures thyroid uptake at selected times between 4 and 24 hours after ingestion. The clinical workflow includes: pretest counseling and medication review (holding interfering medications such as high-dose iodide, amiodarone, or recent iodine contrast when clinically appropriate), verification of pregnancy status in women of childbearing potential, administration of the tracer, timed uptake measurements using a gamma probe or scintillation camera, documentation of uptake percentages, and interpretation to determine whether the gland is overactive (elevated uptake as in Graves disease), underactive (reduced uptake as in thyroiditis), or functioning normally. Results guide management decisions such as antithyroid medication initiation, radioactive iodine therapy planning, or further imaging.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the physician interpretation/report is billed separately from technical services. |
TC |